Meihua International Medical Technologies
MHUA
MHUA was delisted on the 8th of December, 2025.
4 hedge funds and large institutions have $96.8K invested in Meihua International Medical Technologies in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
32% more capital invested
Capital invested by funds: $73.1K → $96.8K (+$23.7K)
0% more funds holding
Funds holding: 4 → 4 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$96.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$16.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.63K |
MHUA Hedge Fund Activity: Q3 2023 in Review
4 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Meihua International Medical Technologies (MHUA) for Q3 2023, worth a combined $96.8K — up 32% from $73.1K a quarter earlier.
Fund positioning in MHUA was balanced in Q3 2023: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $96.4K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $16.3K sold.
- 4 institutional investors held Meihua International Medical Technologies (MHUA) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $96.8K of Meihua International Medical Technologies stock for Q3 2023, up 32% quarter-over-quarter.
- 1 fund opened new Meihua International Medical Technologies positions in Q3 2023 and 1 closed out, a net change of 0 holders.
- The largest Meihua International Medical Technologies buyer in Q3 2023 was Citadel Advisors, an estimated $96.4K added.
- The largest Meihua International Medical Technologies seller in Q3 2023 was Tower Research Capital (TRC), an estimated $16.3K sold.
Based on aggregated 13F filings for Q3 2023.